Avhandlinger
Data fra Norsk Nyreregister har blitt brukt i en rekke doktorgrader, og en oversikt over disse finnes under.
| # | Navn | Tittel | Sted | År |
|---|---|---|---|---|
| 54 | Torbjørn Fossum Heldal | Inflammation following kidney transplantation as risk factor for post-transplant diabetes, graft loss, and mortality | Oslo | 2025 |
| 53 | Yngvar Haaskjold | Prognostic Models in IgA Nephropathy | Bergen | 2024 |
| 52 | Lene Ugilt Pagter Ludvigsen | Epstein-Barr virus infection in kidney transplant recipients – Investigating the clinical relevance and the prospects for prevention of post-transplant lymphoproliferative disorder | Århus | 2024 |
| 51 | Kjersti Benedicte Blom | Viral infections in Norwegian kidney transplant recipients: Impact of COVID-19 and CMV | Oslo | 2024 |
| 50 | Ingvild Andrea Kindem | Medication adherence and home-monitoring among kidney transplanted adolescents and young adults in Norway | Oslo | 2024 |
| 49 | Inga Thorsen | New biomarkers in patients with chronic kidney disease, after kidney transplantation, in kidney donors and in acute myocardial infarction | Stavanger | 2024 |
| 48 | Ida Viken Stalund | Polyvinylpyrrolidone deposition disease: The role of pathology in understanding disease and death in persons with opioid addiction and intravenous drug use | Bergen | 2023 |
| 47 | Vasiliki Tsarpali | Health-related quality of life and survival outcomes in older recipients three years after kidney transplantation | Oslo | 2023 |
| 46 | Rianne Boenink | An overview of international differences and time trends in the epidemiology and outcomes of dialysis and kidney transplantation in Europe | Amsterdam | 2023 |
| 45 | Knut Asbjørn Rise Langlo | Clinical aspects of cardiorenal syndrome | Trondheim | 2022 |
| 44 | Anna Gjerde | Low birth weight, intrauterine growth restriction and risk of chronic kidney disease in adult age | Bergen | 2022 |
| 43 | Rianne W. de Jong | Treatment modality choices for end-stage kidney disease in Europe | Amsterdam | 2021 |
| 42 | Syed Mohammad Husain Rizvi | Long-term dermatological complications after organ transplantation | Oslo | 2020 |
| 41 | Marte Theie Gustavsen | Intelligent tools for individualized immunosuppression in renal transplantation | Oslo | 2020 |
| 40 | Erlend Johannessen Egeland | Pharmacokinetic challenges in renal replacement therapy | Oslo | 2019 |
| 39 | Maria Pippias | The Golden Years: Kidney transplant outcomes in the 21st century | Amsterdam | 2018 |
| 38 | Kjersti Lønning | Health related quality of life and expectations in older patients before and after kidney transplantation | Oslo | 2018 |
| 37 | Rannveig Skrunes | Hereditary renal disease in the Norwegian population, with a focus on Fabry nephropathy | Bergen | 2017 |
| 36 | Thomas Knoop | Prognostic aspects of IgA nephropathy | Bergen | 2017 |
| 35 | Vibeke Gagnum | Mortality, causes of death and end-stage renal disease in type 1 diabetes | Oslo | 2017 |
| 34 | Jørn Petter Hanto Lindahl | Pancreas and kidney transplantation in patients with Type 1 diabetes and end-stage renal disease: Long-term outcomes | Oslo | 2017 |
| 33 | Elisabet Størset | Optimizing tacrolimus treatment in kidney transplant recipients | Oslo | 2017 |
| 32 | Paschal Ruggajo | Low birth weight and the risk of progressive kidney disease | Bergen | 2016 |
| 31 | Christina Dörje | The role of clinical and subclinical inflammation in kidney transplant biopsies | Oslo | 2016 |
| 30 | Ivar Anders Eide | Marine n-3 polyunsaturated fatty acids in renal transplantation | Oslo | 2016 |
| 29 | Dag Olav Dahle | Vascular functions, calcification and clinical outcomes in kidney transplantation | Oslo | 2015 |
| 28 | Inger Hjørdis Bleskestad | Markers of disturbed mineral metabolism in chronic kidney disease | Bergen | 2015 |
| 27 | Marjolein Bonthuis | Nutrition and growth in European children with end-stage renal disease | Amsterdam | 2014 |
| 26 | Moniek van de Luijtgaarden | Starting renal replacement therapy in end-stage renal disease patients | Amsterdam | 2014 |
| 25 | Miriam Kristine Sandvik | Risk factors for development and progression of renal disease | Bergen | 2013 |
| 24 | Camilla Tøndel | Markers of nephropathy in young Fabry disease patients; role of kidney biopsies and functional measurements | Bergen | 2013 |
| 23 | Lene Frøyen Sandvik | Squamous cell carcinomas in renal transplant recipients. Analyses of various dendritic cell populations | Bergen | 2013 |
| 22 | Inger Karin Lægreid | Quality of life in older dialysis patients. Influencing factors and research challenges | Trondheim | 2013 |
| 21 | Einar Gude | Limitations of current treatment strategies in human heart transplantation: Studies on pulmonary hemodynamics, renal failure and immunosuppression | Oslo | 2013 |
| 20 | Tone Brit Hortemo Østhus | Health-related quality of life in patients with endstage renal disease receiving chronic dialysis treatment | Oslo | 2012 |
| 19 | Tone Gretland Valderhaug | New-onset diabetes after renal transplantation. Diagnosis, incidence, and long-term effect on patient survival | Oslo | 2012 |
| 18 | Geir Mjøen | Living kidney donation in Norway | Oslo | 2012 |
| 17 | Hilde Kloster Smerud | Mucosal immunity and treatment options | Uppsala | 2012 |
| 16 | Rune Oskar Bjørneklett | Long-term prognosis in chronic primary glomerulonephritides | Bergen | 2012 |
| 15 | Trine Tangeraas | Survival, cardiorespiratory fitness and quality of life after renal transplantation in childhood: Data from the HENT study | Oslo | 2011 |
| 14 | Anneke Kramer | Epidemiology and outcomes of renal replacement therapy: results from the ERA-EDTA Registry | Amsterdam | 2011 |
| 13 | Gudrun Elisabeth Norby | Renal transplantation in SLE | Oslo | 2010 |
| 12 | Henrik Andreas Bergrem | Hyperglycaemia before and after renal transplantation | Oslo | 2010 |
| 11 | Kristian Heldal | Kidney transplantation in the elderly | Oslo | 2010 |
| 10 | Cecilia Montgomery Øien | Gender aspects in kidney transplantation | Oslo | 2007 |
| 9 | Paul van Dijk | Renal epidemiology in Europe - a registry perspective | Amsterdam | 2007 |
| 8 | Øystein Flesland | Microchimerism after transfusion and transplantation and some associated immunomodulatory effects | Oslo | 2005 |
| 7 | Bjørn Egil Vikse | Renal disease and cardiovascular risk factors after preeclampsia | Bergen | 2004 |
| 6 | Solbjørg Sagedal | Cytomegalovirus infection and disease in renal transplant recipients | Oslo | 2004 |
| 5 | Jøran Hjelmesæth | Glucose intolerance, insulin resistance and cardiovascular risk factor after renal transplantation | Oslo | 2002 |
| 4 | Petter Jensen Gjersvik | Dermatological complications of immunosuppression in kidney and heart transplant recipients | Oslo | 2000 |
| 3 | Anna Varberg Reisæter | Alloimmune responses. Experimental and clinical studies | Oslo | 1998 |
| 2 | Knut Paul Nordal & Eilif Dahl | Renal osteodystrophy in Norway. Aspects of pathogenesis and treatment | Oslo | 1992 |
| 1 | Torbjørn Leivestad | Responses of human T lymphocytes to alloantigens in vivo and in vitro | Oslo | 1989 |